When combined with these habits, the metabolic boost and fat-burning support from the injections can contribute to gradual, sustained weight loss over time
BPC-157 mechanism: Targets localized tissue repair, tendon regeneration, angiogenesis, and gut mucosal healing with a strong preclinical safety record
Need someone to talk to?
Seek urgent same-day assessment or call 999 for emergency care if experiencing: Severe chest pain Severe shortness of breath Fainting or collapse Acute or rapidly worsening neurological deficits (such as new limb weakness, sudden gait disturbance, or bladder/bowel dysfunction) Persistent or worsening anaemia symptoms despite treatmentincluding breathlessness, chest discomfort, palpitations, or extreme fatigueshould trigger medical review
In LiverTox: Clinical and research information on drug-induced liver injury [Internet]
NICE has approved semaglutide (TA875) and liraglutide (TA664) for managing overweight and obesity in specific patient groups within specialist services, subject to prescribing criteria and monitoring requirements
